Glioblastoma Adapts to Anti-VEGF Therapy Through Neuronal Remodeling Signaling Axis
Preclinical glioblastoma models reveal that tumors evade anti-VEGF therapy by activating a transient neuronal-like remodeling program driven by the CTNNB1–NRG3–ERBB4 ...

